Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?

Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?

Abstract

Bibliographic Details
Main Authors:	William J Murphy, Robert J Canter, Sean J Judge, Craig P Collins, Daniel Jaeho Yoon
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/12/3/e008443.full

Similar Items

Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
by: Sean J. Judge, et al.
Published: (2020-02-01)

Improved characterization and translation of NK cells for canine immunotherapy
by: Aryana M. Razmara, et al.
Published: (2024-02-01)

The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
by: Yanlin Yu
Published: (2023-04-01)

The Impact of Obesity on T and NK Cells after LVAD Implantation
by: Eva Katharina Messer, et al.
Published: (2023-05-01)

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans
by: Wiebke Naujoks, et al.
Published: (2020-09-01)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
by: Xinyu Wu, et al.
Published: (2022-12-01)

Mechanisms of Resistance to NK Cell Immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2020-04-01)

NK cell-based tumor immunotherapy
by: Hao Zhang, et al.
Published: (2024-01-01)

NK Cell-Based Glioblastoma Immunotherapy
by: Irene Golán, et al.
Published: (2018-12-01)

NK Cell Dysfunction and Checkpoint Immunotherapy
by: Jiacheng Bi, et al.
Published: (2019-08-01)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
by: Barbara Seliger, et al.
Published: (2022-08-01)

Thymic NK-Cells and Their Potential in Cancer Immunotherapy
by: Forbes C, et al.
Published: (2024-03-01)

NK Cell-Based Immunotherapy in Colorectal Cancer
by: Mariella Della Chiesa, et al.
Published: (2022-06-01)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
by: Sachin Kumar Singh Chauhan, et al.
Published: (2020-07-01)

Editorial: NK cells in viral immunology and immunotherapy
by: Sachin Mulik, et al.
Published: (2023-05-01)

NK Cell-Based Immunotherapy in Cancer Metastasis
by: Seila Lorenzo-Herrero, et al.
Published: (2018-12-01)

Possibilities of using NK cells in cancer immunotherapy
by: Paulina Kwaśnik, et al.
Published: (2020-03-01)

NK cell-based immunotherapies against tumors
by: Radons Jürgen, et al.
Published: (2006-09-01)

NK Cell-Based Immunotherapy in Renal Cell Carcinoma
by: Iñigo Terrén, et al.
Published: (2020-01-01)

Phenotypic diversity of human adipose tissue-resident NK cells in obesity
by: Martha E. Haugstøyl, et al.
Published: (2023-02-01)

The differences of glycodelin and uterus NK cell expression in obese and non-obese rats (Rattus norvegicus)
by: Diyah Nofita Ofa Ningtriyas, et al.
Published: (2021-09-01)

A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer
by: Robert J. Canter, et al.
Published: (2018-08-01)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
by: Raffaella Meazza, et al.
Published: (2023-02-01)

Chasing Uterine Cancer with NK Cell-Based Immunotherapies
by: Vijay Kumar, et al.
Published: (2022-12-01)

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
by: Hansol Lee, et al.
Published: (2021-03-01)

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy
by: Victoria Smith Arnesen, et al.
Published: (2021-10-01)

NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy
by: Adriana Gutiérrez-Hoya, et al.
Published: (2021-11-01)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
by: Synat Kang, et al.
Published: (2021-02-01)

IPSC-derived CAR-NK cells for cancer immunotherapy
by: Xiaotong Lin, et al.
Published: (2023-09-01)

Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
by: Evelyn Ullrich, et al.
Published: (2022-08-01)

NK Cell Metabolism and TGFβ – Implications for Immunotherapy
by: Karen Slattery, et al.
Published: (2019-12-01)

The Advances and Challenges of CAR-NK Cells for Tumor Immunotherapy
by: Ye Ziyun A.
Published: (2019-01-01)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
by: Changqing Pan, et al.
Published: (2021-10-01)

Technical advances in NK cell-based cellular immunotherapy
by: Fang Fang, et al.
Published: (2019-12-01)

NON-VIRAL ENGINEERING OF CAR-NK CELLS FOR CANCER IMMUNOTHERAPY
by: K.R.S. Gomes, et al.
Published: (2020-11-01)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
by: Eunju Shin, et al.
Published: (2023-07-01)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
by: Loredana Cifaldi, et al.
Published: (2023-06-01)

Identification of human NK17/NK1 cells.
by: Abhilash D Pandya, et al.
Published: (2011-01-01)

The role of NK cells in selectin-dependent tumor suppression
by: Sobolev, Olga, Ph. D. Massachusetts Institute of Technology
Published: (2008)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
by: Shafiq Murad, et al.
Published: (2022-05-01)